Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01381029 · ClinicalTrials.gov registry record
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 74
- Enrollment target
NCT01381029: Completed study, sponsored by George Washington University.
NCT01381029 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01381029 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Investigators in the Division of Infectious Diseases are carrying out a study to determine if human immunodeficiency virus (HIV)-seropositive patients receiving the Seasonal Influenza vaccination develop an adequate antibody response. The study group will consist of individuals seen in the Infectious Diseases Clinic who are HIV-seropositive and receive the Seasonal Influenza vaccine.
Primary Outcome
The primary endpoint will be to measure the change from baseline in vaccine-strain specific antibody levels. Titers of \> or = 40 U will be considered protective and a \> 4-fold rise in antibody titer will be considered an adequate response in previously antibody-negative patients. Data from this study will assist in defining the efficacy of the influenza vaccine in the HIV-infected population and the ability of HIV-infected patients to generate an appropriate immune response, as well as maintai
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-08 |
What the finished NCT01381029 record still lists
NCT01381029 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01381029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01381029 about?
NCT01381029 is a clinical study titled "Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals". Investigators in the Division of Infectious Diseases are carrying out a study to determine if human immunodeficiency virus (HIV)-seropositive patients receiving the Seasonal Influenza vaccination develop an adequate antibody response. The study group will consist of individuals seen in the Infectiou...
What is the current status of trial NCT01381029?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2009-09. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01381029?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia